Alkem Laboratories Ltd
Sudhakar Patil has a strong background in research and development within the pharmaceutical industry. Currently serving as a Scientist at Alkem Laboratories Ltd. since October 2021, Sudhakar previously held the position of Senior Officer at Amoli Organics Limited from October 2019 to September 2021, focusing on R&D activities. Prior to that, Sudhakar worked as a Senior Scientific Assistant at Zydus Group from January 2018 to September 2019, where responsibilities included product development. Sudhakar's career began at Granules India Limited as an Officer from July 2015 to December 2017.
This person is not in any teams
This person is not in any offices
Alkem Laboratories Ltd
9 followers
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.